logo

Springworks Therapeutics (SWTX)



Trade SWTX now with
  Date
  Headline
8/30/2021 6:47:29 AM SpringWorks Therapeutics In Research Partnership With Dana-Farber Institute For Nirogacestat In Multiple Myeloma
6/16/2021 6:51:09 AM SpringWorks Therapeutics Begins Phase 1/2 Clinical Trial Of Mirdametinib In Low-Grade Glioma
6/7/2021 6:37:28 AM SpringWorks Collaborate With Seagen To Evaluate Nirogacestat With SEA-BCMA In Patients With R/r Multiple Myeloma
10/26/2020 7:43:48 AM Jazz Pharmaceuticals Ireland And SpringWorks Enter Asset Purchase And Exclusive License Agreement
10/5/2020 6:44:31 AM SpringWorks Therapeutics Announces Clinical Collaboration With Pfizer To Evaluate Nirogacestat With PF-06863135
9/21/2020 7:15:23 AM Precision BioSciences, SpringWorks Therapeutics Collaborate To Evaluate PBCAR269A In Combination With Nirogacestat
9/16/2020 6:33:29 AM SpringWorks Therapeutics Collaborates With Children’s Oncology Group To Conduct Phase 2 Clinical Trial Of Nirogacestat
7/22/2020 6:38:35 AM SpringWorks Announces Full Enrollment Of Phase 3 DeFi Trial Evaluating Nirogacestat
5/26/2020 6:37:09 AM SpringWorks Therapeutics Adds Julie Hambleton To Its Board
5/12/2020 7:38:28 AM SpringWorks Therapeutics Q1 Net Loss $15.3 Mln Or $0.37/shr Vs Loss Of $11.4 Mln Or $5.41/Shr Last Year
3/18/2020 6:34:48 AM SpringWorks Says USPTO Issued U.S. Patent No. 10,590,087